IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-8571

  1. 1,273 Posts.
    lightbulb Created with Sketch. 739
    Thanks for this, I had forgotten about the shortening of review timeframes for each reiteration.

    As you said crossing to the September quarter might work either way as it would therefore include the additional cash from recent oppies and highlight a better Finsbury position to negotiate with investors, but the revenue component would be diminished (but then again US investors understand this) the more R&D a company does the faster it gets to the end goal of commercialisation.

    So failing further market meltdown this cross over to include September quarterlies might be a good thing, but they don't usually get released until around the 20th or so.
    Last edited by Paulfool: 05/10/21
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.